All Resources

A brief overview of the tools available for monitoring people with presymptomatic autoimmune type 1 diabetes, and the pros and cons for each method.

An overview of the screening methods for autoimmune type 1 diabetes (T1D).

Why and Who: an overview of the key considerations and decisions that inform screening people for islet autoantibodies.

Monitoring people with early-stage autoimmune T1D may reduce the risk of serious complications, such as DKA.

Staging of autoimmune T1D allows us to track the progressive nature of the disease, from autoimmunity through to insulin dependence. 

The burden associated with a diagnosis of autoimmune T1D can be wide-ranging. This video describes the impact of diagnosis on an individual and their family.